Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Inventory (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Inventory for 16 consecutive years, with $40.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Inventory fell 2.8% to $40.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $40.7 million, a 2.8% decrease, with the full-year FY2024 number at $38.6 million, up 4.74% from a year prior.
  • Inventory was $40.7 million for Q3 2025 at Xtant Medical Holdings, up from $40.1 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $41.9 million in Q3 2024 to a low of $16.5 million in Q2 2022.
  • A 5-year average of $28.3 million and a median of $21.6 million in 2021 define the central range for Inventory.
  • Peak YoY movement for Inventory: tumbled 32.56% in 2021, then surged 113.39% in 2023.
  • Xtant Medical Holdings' Inventory stood at $17.9 million in 2021, then dropped by 3.68% to $17.3 million in 2022, then soared by 113.39% to $36.9 million in 2023, then increased by 4.74% to $38.6 million in 2024, then increased by 5.38% to $40.7 million in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Inventory are $40.7 million (Q3 2025), $40.1 million (Q2 2025), and $38.8 million (Q1 2025).